Abstract
Endothelial cells are regarded as the main targets of the Shiga toxins (Stxs) during infections caused by Stx-producing Escherichia coli (STEC). However, several investigations also confirmed an effect of these toxins on immune cell functions in species naturally infected with STEC. Human B-cell lines (1) and tonsillar B-cells (2) are highly susceptible to the cytotoxic activity of Stx1, which also hampers activation and proliferation of bovine B- and T- cell subpopulations in vitro (3). Although Stxs appear to be immunosuppressive, they do not prevent the development of a specific antibody response in STECinfected individuals (4–6). Thus, the question of an immunosuppressive effect of Stx in the pathogenesis of STEC-mediated diseases needs to be addressed. STEC infections lead to an immunocompromised condition in gnotobiotic pigs and calves (7,8), which is assumed to contribute to the observed persistency of infection (e.g., in calves and humans) (9,10).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mangeney M., Lingwood C. A., Taga S., Caillou B., Tursz T., and Wiels J. (1993) Apoptosis induced in Burkitt’s lymphoma cells via Gb3/CD77, a glycolipid antigen. Cancer Res. 53, 5314–5319.
Cohen A., Madrid-Marina V., Estrov Z., Freedman M. H., Lingwood C. A., and Dosch H. M. (1990) Expression of glycolipid receptors to Shiga-like toxin on human B lymphocytes: a mechanism for the failure of long-lived antibody response to dysenteric disease. Int. Immunol. 2, 1–8.
Menge C., Wieler L. H., Schlapp T., and Baljer G. (1999) Shiga toxin 1 from Escherichia coli blocks activation and proliferation of bovine lymphocyte subpopulations in vitro. Infect. Immun. 67, 2209–2217.
Pirro F., Wieler L. H., Failing K., Bauerfeind R., and Baljer G. (1995) Neutralizing antibodies against Shiga-like toxins from Escherichia coli in colostra and sera of cattle. Vet. Microbiol. 43, 131–141.
Wieler L. H., Franke S., Menge C., Rose M., Bauerfeind R., Karch H., et al. (1995) Investigations on the immunoresponse during edema disease of piglets after weaning by using a recombinant B subunit of Shiga-like-toxin IIe. Dtsch. Tierarztl. Wochenschr. 102, 40–43.
Reymond D., Johnson R. P., Karmali M. A., Petric M., Winkler M., Johnson S., et al. (1996) Neutralizing antibodies to Escherichia coli Vero cytotoxin 1 and antibodies to O157 lipopolysacccharide in healthy farm family members and urban residents. J. Clin. Microbiol. 34, 2053–2057.
Christopher-Hennings J., Willgohs J. A., Francis D. H., Raman U. A. K., Moxley R. A., and Hurley D. J. (1993) Immunocompromise in gnotobiotic pigs induced by Verotoxin-producing Escherichia coli (O111:NM). Infect. Immun. 61, 2304–2308.
Hoffman M., Casey T., and Bosworth B. (1997) Bovine immune response to Escherichia coli O157, Abstracts of the 3rd International Symposium and Workshop on Shiga Toxin (Verocytotoxin)-producing Escherichia coli infections, p. 117.
Cray W. C. and Moon H. W. (1995) Experimental infection of calves and adult cattle with Escherichia coli O157:H7. Appl. Environ. Microbiol. 61, 1586–1590.
Karch H., Rüssmann H., Schmidt H., Schwarzkopf A., and Heesemann J. (1995) Long-term shedding and clonal turnover of enterohemorrhagic Escherichia coli O157 in diarrheal diseases. J. Clin. Microbiol. 33, 1602–1605.
Klapproth J. M., Scaletsky I. C. A., McNamara B. P., Lai L.-C., Malstrom C., James S. P., et al. (2000) A large toxin from pathogenic Escherichia coli strains that inhibits lymphocyte activation. Infect. Immun. 68, 2148–2155.
Makino K., Ishii K., Yasunaga T., Hattori M., Yokoyama K., Yutsudo C. H., et al. (1998) Complete nucleotide sequences of 93-kb and 3.3-kb plasmids of an enterohemorrhagic Escherichia coli O157:H7 derived from Sakai outbreak. DNA Res. 5, 1–9.
Burland V., Shao Y., Perna N. T., Plunkett G., Sofia H. J., and Blattner F. R. (1998) The complete DNA sequence and analysis of the large virulence plasmid of Escherichia coli O157:H7. Nucleic Acids Res. 26, 4196–4204.
Nicholls L., Grant T. H., and Robins-Browne R. M. (2000) Identification of a novel genetic locus that is required for in vitro adhesion of a clinical isolate of enterohaemorrhagic Escherichia coli to epithelial cells. Mol. Microbiol. 35, 275–288.
Higgins L. M., Frankel G., Connerton I., Goncalves N. S., Dougan G., and MacDonald T. T. (1999) Role of bacterial intimin in colonic hyperplasia and inflammation. Science 285, 588–591.
Tada H., Shiho O., Kuroshima K., Koyama M., and Tsukamoto K. (1986) An improved colorimetric assay for Interleukin 2. J. Immunol. Methods 93, 157–165.
Jacewicz M., Clausen H., Nudelman E., Donohue-Rolfe A., and Keusch G. T. (1986) Pathogenesis of Shigella diarrhea XI: Isolation of a Shigella toxin-binding glycolipid from rabbit jejunum and HeLa-cells and its identification as globotriaosylceramide. J. Exp. Med. 163, 1391–1404.
DeGrandis S., Law H., Brunton J., Gyles C., and Lingwood C. A. (1989) Globotetraosylceramide is recognized by the pig edema disease toxin. J. Biol. Chem. 264, 12,520–12,525.
Wiels J., Fellous M., and Tursz T. (1981) Monoclonal antibody against a Burkitt lymphoma-associated antigen. Proc. Natl. Acad. Sci. USA 78, 6485–6488.
Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., and Riccardi C. (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139, 271–279.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc.
About this protocol
Cite this protocol
Menge, C. (2003). Protocols to Study Effects of Shiga Toxin on Mononuclear Leukocytes. In: Philpott, D., Ebel, F. (eds) E. coli. Methods in Molecular Medicine™, vol 73. Humana Press. https://doi.org/10.1385/1-59259-316-X:275
Download citation
DOI: https://doi.org/10.1385/1-59259-316-X:275
Publisher Name: Humana Press
Print ISBN: 978-0-89603-939-1
Online ISBN: 978-1-59259-316-3
eBook Packages: Springer Protocols